Global EYLEA Drug Market is Segmented By Indication (Wet Age-Related Macular Degeneration (Wet AMD), Diabetic Retinopathy (DR), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (mCNV), and Others), By End User (Hospitals, Ophthalmic Clinics, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.